Business · 21/12/2023Updated: 10/17/2026 · 1 min read
FDA Requests Public Comment on Proposed Study of Direct-to-Consumer Prescription Drug Promotion
Summary
The US Food and Drug Administration (FDA) is seeking public input on a proposed study examining implied claims in direct-to-consumer prescription drug advertising, as required by the Paperwork Reduction Act of 1995.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →